Successful treatment of interstitial lung disease related to Stevens–Johnson syndrome/toxic epidermal necrolysis overlap with etanercept: A case report and published work review-Reference-Cited by-同舟云学术

Successful treatment of interstitial lung disease related to Stevens–Johnson syndrome/toxic epidermal necrolysis overlap with etanercept: A case report and published work review

Published:2019-11 Issue:11 Volume:46 Page:1035-1038
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Wang Fang¹^ORCID,Gao Xuemei¹,Chen Xiaohong¹,Tang Xuhua¹,Chen Haihong²,Han Jiande¹

Affiliation:

1. Department of Dermatology The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

2. Department of Respiratory Medicine The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15058

Reference15 articles.

1. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

2. Severe cutaneous adverse reactions to drugs

3. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up

4. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

5. Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive experience with TNF-α inhibitor in toxic epidermal necrolysis resistant to high-dose systemic corticosteroids;Frontiers in Medicine;2023-07-24

2. Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis;Dermatology and Therapy;2023-05-13

3. Serum levels of C‐C motif chemokine ligand 2 and interleukin‐8 as possible biomarkers in patients with toxic epidermal necrolysis accompanied by acute respiratory distress syndrome;The Journal of Dermatology;2022-11-23

4. Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis;Annals of Allergy, Asthma & Immunology;2022-09

5. A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis;Biomedicines;2022-08-28